Updated
Updated · Bloomberg · Jun 27QuidelOrtho Explores $1.5 Billion Testing Unit Sale as PE Firms Circle
1 articles · Updated · Bloomberg · Jun 27Summary
- $1.5 billion is the valuation QuidelOrtho is seeking for its point-of-care testing unit, according to a Financial Times report.
- Advent International, SK Capital Partners and Archimed are among private equity firms that have expressed interest in the asset, the report said.
- The potential sale would mark a portfolio move by the diagnostics company, with buyer interest suggesting competitive demand for the business.
Insights
Amidst huge losses, is QuidelOrtho's $1.5B sale a desperate retreat or a calculated pivot to a more profitable diagnostics future? Why is QuidelOrtho selling a key unit as the point-of-care market is projected to boom past $130 billion?